Cargando…

Galactose-decorated liver tumor-specific nanoliposomes incorporating selective BRD4-targeted PROTAC for hepatocellular carcinoma therapy

This research deals with the development of asialoglycoprotein receptors (ASGPR) directed nanoliposomes incorporating a novel BRD4 (Bromodomain-containing protein 4) protein-targeted PROTAC (Proteolysis Targeting Chimera), ARV-825 (ARV) (GALARV), and to investigate the anticancer efficacy of GALARV...

Descripción completa

Detalles Bibliográficos
Autores principales:	Saraswat, Aishwarya, Vemana, Hari Priya, Dukhande, Vikas V., Patel, Ketan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8749201/ https://www.ncbi.nlm.nih.gov/pubmed/35036599 http://dx.doi.org/10.1016/j.heliyon.2021.e08702

Ejemplares similares

Palmitoyl Carnitine-Anchored Nanoliposomes for Neovasculature-Specific Delivery of Gemcitabine Elaidate to Treat Pancreatic Cancer
por: Patel, Akanksha, et al.
Publicado: (2022)

EphA2-Receptor Targeted PEGylated Nanoliposomes for the Treatment of BRAF(V600E) Mutated Parent- and Vemurafenib-Resistant Melanoma
por: Fu, Yige, et al.
Publicado: (2019)

Aerosolized nanoliposomal carrier of remdesivir: an effective alternative for COVID-19 treatment in vitro
por: Vartak, Richa, et al.
Publicado: (2021)

Preparation of Benzothiazolyl-Decorated Nanoliposomes
por: Mourtas, Spyridon, et al.
Publicado: (2019)

Development of Dual ARV-825 and Nintedanib-Loaded PEGylated Nano-Liposomes for Synergistic Efficacy in Vemurafnib-Resistant Melanoma
por: Fu, Yige, et al.
Publicado: (2021)

Polypeptide – decorated nanoliposomes as novel delivery systems for lutein
por: Jiao, Yan, et al.
Publicado: (2018)

BRD4-targeting PROTAC as a unique tool to study biomolecular condensates
por: Shi, Yi, et al.
Publicado: (2023)

Antibody–PROTAC Conjugates Enable HER2-Dependent Targeted Protein Degradation of BRD4
por: Maneiro, María, et al.
Publicado: (2020)

The therapeutic effect of the BRD4-degrading PROTAC A1874 in human colon cancer cells
por: Qin, An-cheng, et al.
Publicado: (2020)

Enhanced anti-glioma efficacy of doxorubicin with BRD4 PROTAC degrader using targeted nanoparticles
por: He, Yihong, et al.
Publicado: (2022)

Lethal activity of BRD4 PROTAC degrader QCA570 against bladder cancer cells
por: Wang, Qiang, et al.
Publicado: (2023)

PROTAC-DB: an online database of PROTACs
por: Weng, Gaoqi, et al.
Publicado: (2020)

A Versatile and Sustainable Multicomponent Platform for the Synthesis of Protein Degraders: Proof-of-Concept Application to BRD4-Degrading PROTACs
por: Bhela, Irene Preet, et al.
Publicado: (2022)

BRD4 PROTAC degrader ARV-825 inhibits T-cell acute lymphoblastic leukemia by targeting 'Undruggable' Myc-pathway genes
por: Wu, Shuiyan, et al.
Publicado: (2021)

Estrogen Receptor-α Targeting: PROTACs, SNIPERs, Peptide-PROTACs, Antibody Conjugated PROTACs and SNIPERs
por: Negi, Arvind, et al.
Publicado: (2022)

PROTAC-DB 2.0: an updated database of PROTACs
por: Weng, Gaoqi, et al.
Publicado: (2022)

Modifying the Stability and Surface Characteristic of Anthocyanin Compounds Incorporated in the Nanoliposome by Chitosan Biopolymer
por: Homayoonfal, Mina, et al.
Publicado: (2022)

Advances in Nanoliposomes for the Diagnosis and Treatment of Liver Cancer
por: Li, Yitong, et al.
Publicado: (2022)

A BRD4 PROTAC nanodrug for glioma therapy via the intervention of tumor cells proliferation, apoptosis and M2 macrophages polarization
por: Yang, Tingting, et al.
Publicado: (2022)

Promising galactose-decorated biodegradable poloxamer 188-PLGA diblock copolymer nanoparticles of resibufogenin for enhancing liver cancer therapy
por: Dong, Hao, et al.
Publicado: (2017)

Detection and Quantification of Retinal Neovascularization Using BrdU Incorporation
por: Shao, Yan, et al.
Publicado: (2020)

MALT1-Ubiquitination Triggers Non-Genomic NF-κB/IKK Signaling upon Platelet Activation
por: Karim, Zubair A., et al.
Publicado: (2015)

Effect of topical Nanoliposomes of Paromomycin on Rats Liver and Kidney
por: Kalantari, Heibatullah, et al.
Publicado: (2014)

Non-small molecule PROTACs (NSM-PROTACs): Protein degradation kaleidoscope
por: Ma, Sinan, et al.
Publicado: (2022)

Iterative Design and Optimization of Initially Inactive Proteolysis Targeting Chimeras (PROTACs) Identify VZ185 as a Potent, Fast, and Selective von Hippel–Lindau (VHL) Based Dual Degrader Probe of BRD9 and BRD7
por: Zoppi, Vittoria, et al.
Publicado: (2018)

BRD4 PROTAC degrader MZ1 exerts anticancer effects in acute myeloid leukemia by targeting c-Myc and ANP32B genes
por: Ma, Li, et al.
Publicado: (2022)

PROTACs in gastrointestinal cancers
por: Chen, Yu, et al.
Publicado: (2022)

DeepPROTACs is a deep learning-based targeted degradation predictor for PROTACs
por: Li, Fenglei, et al.
Publicado: (2022)

Development of Agonist-Based PROTACs Targeting Liver X Receptor
por: Xu, Hanqiao, et al.
Publicado: (2021)

PROTAC chemical probes for histone deacetylase enzymes
por: Patel, Urvashi, et al.
Publicado: (2023)

Sorafenib-Loaded Long-Circulating Nanoliposomes for Liver Cancer Therapy
por: Ye, Haiwei, et al.
Publicado: (2020)

A Critical Role for the Transient Receptor Potential Channel Type 6 in Human Platelet Activation
por: Vemana, Hari Priya, et al.
Publicado: (2015)

A Novel BRD Family PROTAC Inhibitor dBET1 Exerts Great Anti-Cancer Effects by Targeting c-MYC in Acute Myeloid Leukemia Cells
por: Zhang, Kunlong, et al.
Publicado: (2022)

The PROTAC technology in drug development
por: Zou, Yutian, et al.
Publicado: (2019)

PROTACs: The Future of Leukemia Therapeutics
por: Anwar, Zubair, et al.
Publicado: (2022)

PROTACs in the Management of Prostate Cancer
por: Yedla, Poornachandra, et al.
Publicado: (2023)

In Vitro Assessment of Cisplatin/Hyaluronan Complex for Loco-Regional Chemotherapy
por: Banella, Sabrina, et al.
Publicado: (2023)

Light-mediated multi-target protein degradation using arylazopyrazole photoswitchable PROTACs (AP-PROTACs)
por: Zhang, Qisi, et al.
Publicado: (2022)

Correction to: Dong et al., Promising galactose-decorated biodegradable poloxamer 188-PLGA diblock copolymer nanoparticles of resibufogenin for enhancing liver cancer therapy
Publicado: (2017)

Protective and therapeutic effects of nanoliposomal quercetin on acute liver injury in rats
por: Liu, Xiangyan, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_vjr9kjadrj4vmbhd29ub298kq5